PLANO, Texas / Aug 05, 2025 / Business Wire / Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a global leader in healthcare communications, today reported that 18 of the 20 adult hospitals featured on the 2025-26 U.S. News & World Report Best Hospitals Honor Roll use Spok technology to enhance care coordination and deliver outstanding patient experiences. For over 10 years, nearly all the top-ranking hospitals have consistently leveraged Spok solutions.
“When our healthcare partners lead with distinction, we celebrate alongside them. This recognition truly represents the incredible work happening in hospitals across the country, and we are proud and honored to be part of that journey,” said Vincent D. Kelly, chief executive officer of Spok Holdings, Inc. “Their deep commitment to clinical excellence inspires everything we do to improve patient care, strengthen teamwork, and ultimately save lives.”
The honorees represent a selection of the over 2,200 hospitals nationwide that rely on Spok solutions to eliminate communication barriers, streamline workflows, and enhance patient experiences. As the global authority on hospital rankings, the U.S. News & World Report has compiled the 2025-26 U.S. News & World Report Best Hospitals Honor Roll for over three decades. This recognition program evaluates approximately 4,500 healthcare organizations annually, naming 20 of the country’s highest-performing hospitals among 15 specialties and 22 procedures and conditions. The rankings are based primarily on a methodology that analyzes care-related indicators such as mortality, unplanned readmissions, infection prevention, prolonged hospitalizations, nurse staffing and communication, patient experience, and timely treatments.
About Spok
Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK), headquartered in Plano, Texas, is proud to be a global leader in healthcare communications. We deliver clinical information to care teams when and where it matters most to improve patient outcomes. Top hospitals rely on the Spok Care Connect® platform to enhance workflows for clinicians and support administrative compliance. Our customers send over 70 million messages each month through their Spok® solutions. Spok enables smarter, faster clinical communication. For more information, visit spok.com.
| Last Trade: | US$13.90 |
| Daily Change: | 0.07 0.51 |
| Daily Volume: | 98,708 |
| Market Cap: | US$286.340M |
October 29, 2025 July 30, 2025 April 30, 2025 February 26, 2025 October 30, 2024 | |

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load